The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.
Recommended - Individuals: transactions
Arnold & Porter is one of the most sought-after founts of IP expertise in the life sciences industry and a premier destination for big-ticket pharmaceutical and medical device patent litigation. In-house counsel speak in glowing terms about the group, which “doesn’t approach litigation as a theoretical exercise but as a practical means to achieve a commercial outcome. Working with the team, you get a very clear sense of the risks and rewards that come with different strategies, which is hugely valuable when you’re managing litigation from a business perspective.” Many instructions land on the desk of Deborah Fishman, who is known for her razor-sharp advocacy. She is a lead member of a well-specced California, New York and DC team of elite professionals defending Regeneron’s patents protecting EYELEA, a product that generates $8 billion in yearly revenue. Michael Berta lends weight to pharmaceutical representations but leans towards high-technology and computer-focused cases. Taking on diverse cases he stays sharp and ready for anything, and recently masterminded a design patents win for Crocs at the Federal Circuit. The firm’s technology transactions offering recently took a hit following the departure of DC-based Susan Hendrickson, who now serves at Harvard University’s Berkman Klein Center for Internet & Society as executive director. However, it remains strong under the leadership of Thomas Magnani. “Tom is extremely knowledgeable and detail oriented and 100% plugged into the competitive markets in which his clients operate.” Among his patrons is high-growth, IP-focused company Fullpower Technologies, which is innovating in the Internet-of-Things and AI space; he recently advised it in a number of strategic partnerships, including with Nike.